Phillip G Febbo1,2,3
, Mike G Mulligan4
, David A Slonina4
, Kimberly Stegmaier5
, Dolores Di Vizio6
, Paul R Martinez4
, Massimo Loda6
and Stephen C Taylor4 
1Institute for Genome Science and Policy, Duke University, Durham, North Carolina, USA
2Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA
3Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA
4Acumenta Corporation, Boston, Massachusetts, USA
5Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
6Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA